A-3922

dihydrobenzofuran derivative

Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

1.	Corneal Neovascularization 02/01/2007 - "The aim of this study was to investigate the effect of A-3922, a dihydrobenzofuran derivative, on linoleic acid hydroperoxide (LHP)-induced corneal neovascularization (NV) in a rabbit model. "
2.	Cataract (Cataracts) 10/01/2008 - "The present study was undertaken to assess whether A-3922, a dihydrobenzofuran derivative that possesses antioxidative effects, had any preventive effect on the onset and/or progression of diabetic cataract. " 10/01/2008 - "These results suggest that A-3922 can delay the progression but not the onset of diabetic cataract, and it has a possibility to be a candidate for drugs of cataract associated with diabetes." 10/01/2008 - "The lens opacities were initially detected as early as the 2nd week and the cataracts were developed in similar fashion in both A-3922-treated and untreated diabetic rats until 7th week, suggesting that A-3922 did not show any appreciable effect on the onset of diabetic cataract. " 10/01/2008 - "Attenuation of cataract progression by A-3922, a dihydrobenzofuran derivative, in streptozotocin-induced diabetic rats."

1.	linoleic acid hydroperoxide
2.	Streptozocin (Streptozotocin)